Pulmonary hypertension and nailfold capillaroscopic pattern in systemic sclerosis patients treated with Iloprost and Bosentan: Preliminary report

被引：0
|
作者：
Bellissimo, S
Di Girolamo, C
Ferrucci, MG
Gallo, A
Venditti, C
Stisi, S
机构：
[1] Gaetano Rummo Hosp, Rheumatol Unit, Benevento, Italy
[2] Gaetano Rummo Hosp, Rheumatol Unit, Benevento, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [41] Morbidity and mortality in patients with pulmonary hypertension treated with iloprost
    Martinez, L. C. Liz Carolina Casafuz
    Chamorro, F. N. G. Fernandez
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 146 - 146
  • [42] Four Year Effects of Combined Bosentan and Iloprost Treatment on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion and Clinical Status, in Systemic Sclerosis Patients
    Trombetta, Amelia Chiara
    Pizzorni, Carmen
    Ruaro, Barbara
    Paolino, Sabrina
    Sulli, Alberto
    Smith, Vanessa
    Cutolo, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] Long term treatment with bosentan for pulmonary arterial hypertension related to systemic sclerosis
    Cozzi, F
    Montisci, R
    Marotta, H
    Bobbo, F
    Favaro, M
    Tiso, F
    Ciprian, L
    Iliceto, S
    Todesco, S
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 297 - 297
  • [44] Treatment of severe pulmonary arterial hypertension related to systemic sclerosis: Experience with bosentan
    Ahmadi-Slmab, K
    Hellmich, B
    Gross, WL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 294 - 294
  • [45] Pulmonary hypertension in patients with systemic sclerosis
    Ciurzynski, Michal
    Bienias, Piotr
    Pruszczyk, Piotr
    KARDIOLOGIA POLSKA, 2007, 65 (08) : 994 - 1000
  • [46] Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Hasegawa, Minoru
    Matsushita, Takashi
    Takehara, Kazuhiko
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 55 (01) : 66 - 67
  • [47] Protective effect of Bosentan on vascular endothelium in patients with pulmonary arterial hypertension (PAH) related to systemic sclerosis
    Del Papa, N
    Cortiana, M
    Comina, DP
    Maglione, W
    Manara, M
    Vitali, C
    Fracchiolla, N
    Cortelezzi, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 299 - 299
  • [48] Impact of iloprost and bosentan therapy on the outcome of patients with end-stage primary pulmonary hypertension
    Dandel, M.
    Lehmkuhl, H. B.
    Weng, Y.
    Mulahasanovic, S.
    Grauhan, O.
    Kuosalla, C.
    Hetzer, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S176 - S176
  • [49] Outcome of patients with primary pulmonary hypertension after listing for transplantation:: Benefits of therapy with iloprost and bosentan
    Dandel, M.
    Lehmkuhl, H. B.
    Weng, Y.
    Mutuhasanovic, S.
    Boettcher, H.
    Knosalla, C.
    Grauhan, O.
    Hetzer, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S157 - S157
  • [50] Retinal Microvasculature in Systemic Sclerosis Patients and the Correlation between Nailfold Capillaroscopic Findings and Optical Coherence Angiography Results
    Paczwa, Katarzyna
    Rerych, Magdalena
    Romanowska-Prochnicka, Katarzyna
    Olesinska, Marzena
    Rozycki, Radoslaw
    Golebiewska, Joanna
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
12345